Email story to a friend Email story to a friendPrintable version Printable version

GlaxoSmithKline wins approval for bird flu vaccine

Date: 19 May 2008

GlaxoSmithKline has been granted EU approval for a new vaccine designed to combat the feared outbreak of a human-spread variant of the H5N1 bird influenza.

The company's Prepandrix will become the first vaccine for use in this eventuality, and various governments have already begun to stockpile the drug for the possible instance that the virus mutates from being a disease almost exclusively affecting birds to one that could be deadly to humans.


You must be logged in to add comments

No comments added - be the first!

Similar news stories

From the same country

Other stories about this company

Currently most popular stories